Insurance Guidelines Lead to Greater Out-of-Pocket Costs for Patients With MS Managed Markets Network

The high cost of Multiple Sclerosis (MS) therapies has created an access problem for patients who can't afford the medications due to high out-of-pocket costs.

Read full article on


Follow Us on Twitter

Follow Us On Twitter - Image